Latest Insider Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL)
This section provides a real-time view of insider transactions for Zentalis Pharmaceuticals, Inc. (ZNTL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zentalis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zentalis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.38%
|
$240,000
$24.49 P/Share
|
|
Jan 05
2023
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.35%
|
$210,000
$21.24 P/Share
|
|
Nov 15
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.63%
|
$287,500
$23.1 P/Share
|
|
Nov 09
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
30,000
-3.69%
|
-
|
|
Nov 08
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,374
-3.12%
|
$284,602
$23.56 P/Share
|
|
Nov 07
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.53%
|
$287,500
$23.95 P/Share
|
|
Oct 17
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-2.96%
|
$287,500
$23.51 P/Share
|
|
Oct 06
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-2.32%
|
$220,000
$22.62 P/Share
|
|
Oct 05
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.42%
|
$275,000
$22.38 P/Share
|
|
Oct 03
2022
|
Epperly Melissa B, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+14.39%
|
-
|
|
Oct 03
2022
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.79%
|
-
|
|
Oct 03
2022
|
Carrie Brownstein Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 16
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.1%
|
$240,000
$24.68 P/Share
|
|
Sep 15
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
12,500
-1.35%
|
$312,500
$25.35 P/Share
|
|
Sep 09
2022
|
Jan Skvarka Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,606
+50.0%
|
-
|
|
Aug 10
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-5.0%
|
$150,000
$30.0 P/Share
|
|
Jul 20
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-4.76%
|
$150,000
$30.0 P/Share
|
|
Jul 14
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,290
-3.04%
|
$98,700
$30.01 P/Share
|
|
Jul 13
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
1,710
-1.55%
|
$51,300
$30.02 P/Share
|
|
Jul 05
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-18.52%
|
$750,000
$30.07 P/Share
|
|
Jun 08
2022
|
Enoch Kariuki Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,817
+50.0%
|
-
|
|
Jun 08
2022
|
David Michael Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,871
+18.67%
|
-
|
|
May 30
2022
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
111,072
+19.22%
|
-
|
|
Apr 11
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-1.19%
|
$155,000
$31.98 P/Share
|
|
Apr 05
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.69%
|
$510,000
$51.17 P/Share
|
|
Apr 05
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.44%
|
$534,021
$51.73 P/Share
|
|
Apr 04
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.88%
|
$502,608
$48.5 P/Share
|
|
Apr 04
2022
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,080
-1.32%
|
$854,000
$50.76 P/Share
|
|
Mar 21
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-3.39%
|
$490,000
$49.11 P/Share
|
|
Mar 15
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.89%
|
$420,000
$42.31 P/Share
|
|
Mar 10
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-2.13%
|
$470,000
$47.13 P/Share
|
|
Mar 07
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.3%
|
$450,000
$45.23 P/Share
|
|
Mar 02
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.43%
|
$523,550
$50.51 P/Share
|
|
Mar 01
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.43%
|
$513,079
$49.9 P/Share
|
|
Feb 23
2022
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,913
-0.36%
|
$93,737
$49.2 P/Share
|
|
Feb 22
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-1.49%
|
$490,000
$49.09 P/Share
|
|
Feb 15
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.85%
|
$520,000
$52.04 P/Share
|
|
Feb 14
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
4,733
-0.19%
|
$236,650
$50.46 P/Share
|
|
Feb 14
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
7,188
-0.6%
|
$359,400
$50.36 P/Share
|
|
Feb 14
2022
|
Alexis Pinto Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
691
-1.51%
|
$34,550
$50.46 P/Share
|
|
Feb 14
2022
|
Dimitris Voliotis SVP, Clinical Development |
SELL
Open market or private sale
|
Direct |
601
-1.82%
|
$30,050
$50.46 P/Share
|
|
Feb 14
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,688
-0.2%
|
$234,400
$50.4 P/Share
|
|
Feb 10
2022
|
Anthony Y Sun President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,431
+3.96%
|
-
|
|
Feb 10
2022
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,798
+1.94%
|
-
|
|
Feb 10
2022
|
Epperly Melissa B, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,405
+5.8%
|
-
|
|
Feb 10
2022
|
Alexis Pinto Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,405
+41.7%
|
-
|
|
Feb 10
2022
|
Dimitris Voliotis SVP, Clinical Development |
BUY
Grant, award, or other acquisition
|
Direct |
10,329
+38.39%
|
-
|
|
Feb 10
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-1.42%
|
$530,000
$53.63 P/Share
|
|
Feb 10
2022
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,481
+2.84%
|
-
|
|
Feb 07
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.84%
|
$530,000
$53.54 P/Share
|